Record view
- Product type
- api
- Audit evidence
- No audit report on record.
- Record verified
- 21 August 2026
Official product photograph required — MSN Group, API manufacturing — DMF portfolio (not itemised per molecule)
Public Product Record
As published by the manufacturer- Specification
- MSN Group's own regulatory page states an aggregate portfolio of 529 US DMFs, 181 EU DMFs and 160 CEPs across its API business as of the date accessed below. This is a company-level aggregate claim, not a per-molecule filing — no single molecule name or DMF number is asserted by this record.
- Packing
- Not published — quoted against your specification
- MOQ
- Not published — quoted against your specification
- Lead time
- Not published — quoted against your specification
- HS code
- Not published — quoted against your specification
- Price
- Not published — quoted against your specification
Regulatory record — Active Pharmaceutical Ingredient
Verified 21 August 2026- US DMF number
- Not published
- US DMF status
- Not published
- CEP status
- Not published
- Letter of Access
- Not published
- LoA turnaround
- Not published
- Last US FDA inspection
- Not published
- Inspection outcome
- Not published
- Pharmacopoeia
- Not published
- Capacity available now
- Not published
- US supply active
- Not published
- Backward integrated
- Not published
- Multi-site
- Not published
Audit evidence
Licensed in from the accredited body named — never an Indiasay auditNo audit report on record.
Documentation available
Released against a named consignee- ·Certificate of analysis for the supplied lot
- ·Specification sheet, countersigned
- ·Packing list and lot coding
- ·Origin declaration
- ·Destination-market documentation per the category guide
Released against a named consignee. Held by the manufacturer, transmitted by Indiasay.